1. Home
  2. BMY
  3. BMY News

Latest Bristol-Myers Squibb Company (BMY) News on May 28, 2025

BMY

MT Newswires

9 hours ago

Bristol Myers Squibb Gets EC Approval for Subcutaneous Formulation of Opdivo

Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
BMY

Business Wire

10 hours ago

Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications
BMY

Business Wire

10 hours ago

Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

BMY

MT Newswires

11 hours ago

Berenberg Adjusts Price Target on Bristol-Myers Squibb to $55 From $60, Maintains Hold Rating

Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down
BMY

Zacks

a day ago

Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down

Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?
BMY

Zacks

2 days ago

Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?

Bristol-Myers Squibb (NYSE:BMY) Showcases Breakthrough Oncology Data at ASCO 2025 Meeting
BMY

Simply Wall St.

5 days ago

Bristol-Myers Squibb (NYSE:BMY) Showcases Breakthrough Oncology Data at ASCO 2025 Meeting

EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort
BMY

Zacks

5 days ago

EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort

With 81% ownership, Bristol-Myers Squibb Company (NYSE:BMY) boasts of strong institutional backing
BMY

Simply Wall St.

5 days ago

With 81% ownership, Bristol-Myers Squibb Company (NYSE:BMY) boasts of strong institutional backing

Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
BMY

Business Wire

6 days ago

Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline

BMY

StockStory

7 days ago

1 Safe-and-Steady Stock to Own for Decades and 2 to Think Twice About

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)
BMY

StockStory

7 days ago

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)

Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions Conference
BMY

Business Wire

7 days ago

Bristol Myers Squibb to Participate in the Bernstein 41st Annual Strategic Decisions Conference

Here's How You Can Earn $100 In Passive Income By Investing In Bristol-Myers Squibb Stock
BMY

Benzinga

8 days ago

Here's How You Can Earn $100 In Passive Income By Investing In Bristol-Myers Squibb Stock

Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?
BMY

Zacks

9 days ago

Amgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?

EC approves BMS’ perioperative Opdivo and chemo for NSCLC
BMY

Pharmaceutical Technology

9 days ago

EC approves BMS’ perioperative Opdivo and chemo for NSCLC

Judge shuts down drugmakers’ 340B rebate plans, for now
BMY

Healthcare Dive

10 days ago

Judge shuts down drugmakers’ 340B rebate plans, for now

Jim Cramer On Bristol-Myers Squibb: “Waiting For It To Bottom”
BMY

Insider Monkey

12 days ago

Jim Cramer On Bristol-Myers Squibb: “Waiting For It To Bottom”

Bristol-Myers Squibb (NYSE:BMY) Gains EC Approval for Opdivo in Lung Cancer Treatment
BMY

Simply Wall St.

12 days ago

Bristol-Myers Squibb (NYSE:BMY) Gains EC Approval for Opdivo in Lung Cancer Treatment

BMY

MT Newswires

12 days ago

Bristol-Myers Squibb Receives European Approval for Opdivo Regimen to Treat Lung Cancer

Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%
BMY

Business Wire

12 days ago

Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer with PD-L1 Expression ≥1%

Jefferies not seeing significant impact to Merck, Bristol from draft guidance
BMY

TipRanks

13 days ago

Jefferies not seeing significant impact to Merck, Bristol from draft guidance

What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks
BMY

Motley Fool

13 days ago

What Most-Favored-Nation Status Could Mean for Pharmaceutical Stocks

BMY

Morningstar Research

14 days ago

Analyst Report: Bristol-Myers Squibb Company

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
BMY

Zacks

14 days ago

Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know

Why Bristol-Myers Squibb Company (BMY) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom
BMY

Insider Monkey

15 days ago

Why Bristol-Myers Squibb Company (BMY) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom

Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News
BMY

Investor's Business Daily

15 days ago

Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News

Drugmakers Avoid Worst-Case Pricing Scenario for Now
BMY

The Wall Street Journal

16 days ago

Drugmakers Avoid Worst-Case Pricing Scenario for Now

BMY

Morningstar Research

16 days ago

Analyst Report: Bristol-Myers Squibb Company

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order
BMY

Yahoo Finance

16 days ago

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order

BMY

MT Newswires

16 days ago

Bristol-Myers Squibb, Sanofi Enter $700 Million Settlement With Hawaii in Plavix Lawsuit

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower
BMY

Bloomberg

16 days ago

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements
BMY

StockStory

16 days ago

BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid Pipeline Advancements

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices
BMY

Bloomberg

17 days ago

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

Bristol-Myers Squibb Company (BMY): One of the Best High-Yield Dividend Stocks for 2025 and Beyond
BMY

Insider Monkey

19 days ago

Bristol-Myers Squibb Company (BMY): One of the Best High-Yield Dividend Stocks for 2025 and Beyond

BMY

Associated Press Finance

19 days ago

Drug companies to pay Hawaii $700 million to settle Plavix blood thinner lawsuit

3 Healthcare Stocks in Hot Water
BMY

StockStory

20 days ago

3 Healthcare Stocks in Hot Water

A Look at Pharma ETFs After Strong Q1 Earnings
BMY

Zacks

20 days ago

A Look at Pharma ETFs After Strong Q1 Earnings

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock
BMY

Zacks

20 days ago

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

The Zacks Analyst Blog Highlights Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle
BMY

Zacks

20 days ago

The Zacks Analyst Blog Highlights Verizon Communications, Bristol-Myers Squibb, Canadian Pacific and Nova LifeStyle

Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific
BMY

Zacks

21 days ago

Top Research Reports for Verizon Communications, Bristol-Myers Squibb & Canadian Pacific

Improving Access to Care by Strengthening Local Health System Capacity
BMY

ACCESS Newswire

21 days ago

Improving Access to Care by Strengthening Local Health System Capacity

Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel
BMY

Simply Wall St.

22 days ago

Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel

Bristol Myers Squibb announces $40bn US investment plan over five years
BMY

Pharmaceutical Technology

22 days ago

Bristol Myers Squibb announces $40bn US investment plan over five years

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer
BMY

Business Wire

22 days ago

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings
BMY

StockStory

23 days ago

Elanco (ELAN) Reports Q1: Everything You Need To Know Ahead Of Earnings

Bristol Myers to invest $40 billion in the US over 5 years
BMY

Reuters

23 days ago

Bristol Myers to invest $40 billion in the US over 5 years

Was Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?
BMY

Insider Monkey

23 days ago

Was Jim Cramer Right About Bristol-Myers Squibb Company (BMY)?

Supernus Pharmaceuticals Earnings: What To Look For From SUPN
BMY

StockStory

24 days ago

Supernus Pharmaceuticals Earnings: What To Look For From SUPN

1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar
BMY

StockStory

a month ago

1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar

Jim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia Drug
BMY

Insider Monkey

a month ago

Jim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia Drug

Bristol-Myers Squibb's (NYSE:BMY) Strong Earnings Are Of Good Quality
BMY

Simply Wall St.

a month ago

Bristol-Myers Squibb's (NYSE:BMY) Strong Earnings Are Of Good Quality

BMY

MT Newswires

a month ago

Piper Sandler Adjusts Bristol-Myers Squibb's Price Target to $66 From $65

BMY

MT Newswires

a month ago

Bristol-Myers' New Injection Version of Opdivo Gets UK Approval

This High-Yield Pharma Stock Looks Like an Incredible Bargain
BMY

Motley Fool

a month ago

This High-Yield Pharma Stock Looks Like an Incredible Bargain

BMY

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 04/30/2025

Is Bristol-Myers Squibb Company (BMY) the Best Long-Term Dividend Stock to Buy According to Billionaires?
BMY

Insider Monkey

a month ago

Is Bristol-Myers Squibb Company (BMY) the Best Long-Term Dividend Stock to Buy According to Billionaires?

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
BMY

Zacks

a month ago

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

BMY

MT Newswires

a month ago

Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $48 From $54, Maintains Neutral Rating

Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’
BMY

Insider Monkey

a month ago

Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’

BMSCH announces Children’s Same Day Services centre in the US
BMY

Hospital Management

a month ago

BMSCH announces Children’s Same Day Services centre in the US

BMY

MT Newswires

a month ago

HSBC Adjusts Bristol-Myers Squibb Price Target to $47 From $56, Maintains Hold Rating

BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?
BMY

Zacks

a month ago

BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
BMY

Motley Fool

a month ago

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

Bristol-Myers Squibb First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
BMY

Simply Wall St.

a month ago

Bristol-Myers Squibb First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.
BMY

Barrons.com

a month ago

Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.

BMY

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $56 From $55, Maintains Neutral Rating

BMY

MT Newswires

a month ago

Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $53 From $62, Maintains Equalweight Rating

Company News for Apr 25, 2025
BMY

Zacks

a month ago

Company News for Apr 25, 2025

Bristol-Myers Squibb Company (BMY): A Growing Dividend Stock with Low PE Ratio
BMY

Insider Monkey

a month ago

Bristol-Myers Squibb Company (BMY): A Growing Dividend Stock with Low PE Ratio

BMY

Argus Research

a month ago

Analyst Report: Bristol-Myers Squibb Co.

BMY

Argus Research

a month ago

Market Digest: GOLD, BMY, CSX, DFS, FE, GPC, GAP, HBAN, IBM, LRCX, NEM, T, TXN, ELV, KDP, GEV

Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy.
BMY

Barrons.com

a month ago

Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy.

BMY

Morningstar Research

a month ago

Analyst Report: Bristol-Myers Squibb Company

Bristol Myers Squibb Reverses Its Losing Spree On First-Quarter Beat
BMY

Investor's Business Daily

a month ago

Bristol Myers Squibb Reverses Its Losing Spree On First-Quarter Beat

BMY

MT Newswires

a month ago

JPMorgan Cuts Price Target on Bristol-Myers Squibb to $67 From $70

Stocks Drift on Earnings as US-China Hopes Falter: Markets Wrap
BMY

Bloomberg

a month ago

Stocks Drift on Earnings as US-China Hopes Falter: Markets Wrap

Drugmakers brace for Trump tariffs with production shifts
BMY

Reuters

a month ago

Drugmakers brace for Trump tariffs with production shifts

Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations
BMY

StockStory

a month ago

Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations

BMY

MT Newswires

a month ago

Bristol-Myers Squibb Swings to Q1 Earnings, Reports Lower Revenue; Updates Full-Year 2025 Guidance

Bristol Myers Squibb Posts Better-than-Expected Earnings, Raises Full-Year Guidance
BMY

Barrons.com

a month ago

Bristol Myers Squibb Posts Better-than-Expected Earnings, Raises Full-Year Guidance

BMY

Associated Press Finance

a month ago

Bristol Myers: Q1 Earnings Snapshot

Bristol Myers posts better-than-expected quarterly revenue on strong cancer drug sales
BMY

Reuters

a month ago

Bristol Myers posts better-than-expected quarterly revenue on strong cancer drug sales

Bristol Myers Squibb Reports First Quarter Financial Results for 2025
BMY

Business Wire

a month ago

Bristol Myers Squibb Reports First Quarter Financial Results for 2025

BMY

MT Newswires

a month ago

Citigroup Adjusts Bristol-Myers Squibb Price Target to $51 From $55

Bristol Myers Stock Falls After Drug Trial Setback. Why 1 Analyst Isn’t Worried.
BMY

Barrons.com

a month ago

Bristol Myers Stock Falls After Drug Trial Setback. Why 1 Analyst Isn’t Worried.

Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect
BMY

StockStory

a month ago

Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect

These Stocks Are Moving the Most Today: Tesla, Intel, Bristol Myers, SAP, Boeing, AT&T, and More
BMY

Barrons.com

a month ago

These Stocks Are Moving the Most Today: Tesla, Intel, Bristol Myers, SAP, Boeing, AT&T, and More

BMY

MT Newswires

a month ago

Deutsche Bank Adjusts Bristol-Myers Squibb Price Target to $51 From $53, Maintains Hold Rating

BMY

Clinical Trials Arena

a month ago

BMS’ schizophrenia therapy fails in Phase III trial as an adjunctive treatment

Bristol Myers’ prized schizophrenia drug stumbles in testing
BMY

BioPharma Dive

a month ago

Bristol Myers’ prized schizophrenia drug stumbles in testing

Bristol Myers Sheds 6% After Promising Schizophrenia Drug Flops In Phase 3 Test
BMY

Investor's Business Daily

a month ago

Bristol Myers Sheds 6% After Promising Schizophrenia Drug Flops In Phase 3 Test

Patent Cliff Looms Large for Bristol-Myers Squibb Stock (BMY)
BMY

TipRanks

a month ago

Patent Cliff Looms Large for Bristol-Myers Squibb Stock (BMY)

BMY

MT Newswires

a month ago

Piper Sandler Initiates Bristol-Myers Squibb at Overweight With $65 Price Target

BMY

MT Newswires

a month ago

Bristol-Myers Says US FDA Updates Prescribing Information for Cardiac Myosin Inhibitor Camzyos

Bristol Myers says FDA updates Camzyos label to simplify treatment
BMY

TipRanks

a month ago

Bristol Myers says FDA updates Camzyos label to simplify treatment

Bristol-Myers Squibb (NYSE:BMY) Gains FDA Approval To Simplify Camzyos Monitoring Process
BMY

Simply Wall St.

a month ago

Bristol-Myers Squibb (NYSE:BMY) Gains FDA Approval To Simplify Camzyos Monitoring Process

Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
BMY

Zacks

a month ago

Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics

U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
BMY

Business Wire

a month ago

U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?
BMY

Zacks

a month ago

Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?

Share on Social Networks: